Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 93 results found. Search for [ malaria ]

Results 60 to 80 of 93
www.businesstoday.in
New Delhi, June 20, 2012
Japanese pharma major Daiichi Sankyo will start selling Ranbaxy Laboratories products in Venezuela under their hybrid business model.


www.businesstoday.in
New York, June 13, 2012
On Day 15, Geetanjali Gupta told the jury that she would do \"anything' to help her father, Rajat Gupta, former global head of McKinsey & Co., who is standing trial for insider trading.


www.businesstoday.in
New York, June 12, 2012
A US judge trying former Goldman Sachs director Rajat Gupta for insider trading has tentatively ruled against allowing wiretaps that suggest another Goldman insider behind the alleged tips to hedge fund billionaire Raj Rajaratnam.


www.businesstoday.in
June 12, 2012
On Day 14, Geetanjali Gupta, testified on behalf of her father Rajat Gupta, former global head of consultancy firm McKinsey & Co., who is facing charges of insider trading.


www.businesstoday.in
June 9, 2012
On Day 13, the US government concluded its arguments in the trial of Rajat Gupta, the former global head of McKinsey & Co., who has been charged with insider trading.


www.businesstoday.in
May 24, 2012
As Rajat Gupta faces trial, Betwa Sharma, reporting from New York, says his fate hinges on whether the judge will dismiss wiretaps as hearsay.


www.businesstoday.in
New Delhi, May 22, 2012
The antibiotic combination of carbapenem and aminoglycoside is to be used for treating bacterial infections.


www.businesstoday.in
May 22, 2012
Dressed in a dark suit, the former global head of McKinsey & Co., sat quietly in the courtroom as the long- anticipated legal drama unfolded around him.


www.businesstoday.in
Accra (Ghana), May 11, 2012
Ranbaxy Laboratories has boosted its presence in the emerging market of Africa, introducing its new malaria-fighting drug Synriam and setting up manufacturing facilities in Morocco, Nigeria and South Africa.


www.businesstoday.in
New Delhi, May 9, 2012
Net sales of the company rose to Rs 3,695.40 crore for the quarter ended March 31, 2012, as against Rs 2,141.49 crore during the same period of previous year.


www.businesstoday.in
May 11, 2012
After successful clinical trials and approvals, the new anti-malaria drug Synriam, developed by Ranbaxy, was finally launched on April 25. Indigenously developed, the drug launch underlines the importance of government-industry collaboration.


www.businesstoday.in
New Delhi, April 26, 2012
Synriam, priced at Rs. 130 for three tablets, is a three-day course.  The three-tablet module sets it apart from alternative therapies which require a 2-4 tablet dosage per day.


www.businesstoday.in
January 3, 2012
Innovation is the answer and there are ways to accelerate it, says Vijay Govindarajan.


www.businesstoday.in
December 20, 2011
The country is in poor health, and private hospitals can do little to improve it.


www.businesstoday.in
New Delhi, December 1, 2011
Drug major Ranbaxy Laboratories launches its generic version of blockbuster cholesterol - lowering drug Lipitor in the US market after getting an approval from the US health regulator to manufacture it.


www.businesstoday.in
New Delhi, December 1, 2011
The US health regulator's move to grant approval to Ranbaxy Laboratories to produce generic version of cholesterol lowering drug Lipitor will help the India-based firm to launch the drug in the American market.


www.businesstoday.in
November 12, 2011
Here's news for those who think that computer games kill imagination - and brain cells.


www.businesstoday.in
November 24, 2011
Ranbaxy is set to become the first home-grown company to get a new drug to market.


www.businesstoday.in
New Delhi, August 31, 2011
The company said it will spend over Rs 10 crore along with parent company Daiichi Sankyo over the next five years to sponsor mobile healthcare field clinics in India, Cameroon and Tanzania.


www.businesstoday.in
August 3, 2011
He may be an NRI who spends half the year abroad, but Cipla's Chairman Yusuf Khwaja Hamied, 74, tracks developments in India and in his company every minute, while also keeping himself abreast of global scientific developments and market trends. He spoke to BT from Spain on his vision for Cipla. Edited excerpts:


PAGES 4 OF 5  12345